Table 1.
Patient. No. | Group | Age | Sex | BH (cm) | BW (kg) | Dose (MBq) | PSA (ng/ml) | Positive biopsy | Gleason score |
---|---|---|---|---|---|---|---|---|---|
1 | WB | 75 | M | 158.5 | 45.1 | 93.8 | 452.9 | 6/8 | 4+4 |
2 | WB | 65 | M | 166.7 | 57.8 | 130.2 | 2177.6 | 8/8 | 5+4 |
3 | WB | 65 | M | 157.8 | 73.6 | 164.7 | 647.0 | 5/8 | 4+5 |
4 | WB | 75 | M | 168.0 | 69.0 | 217.5 | 111.3 | 6/6 | 4+5 |
5 | WB | 54 | M | 159.7 | 69.9 | 287.8 | 13.5 | 7/8 | 5+4 |
6 | Dyn | 70 | M | 174.0 | 78.1 | 201.9 | 4.8 | 3/8 | 3+4 |
7 | Dyn | 75 | M | 164.8 | 66.0 | 194.8 | 134.5 | 4/8 | 4+3 |
8 | Dyn | 75 | M | 161.1 | 63.2 | 202.4 | 104.6 | 8/8 | 4+4 |
9 | Dyn | 81 | M | 149.0 | 57.6 | 194.3 | 41.1 | 9/10 | 5+5 |
10 | Dyn | 64 | M | 166.0 | 65.2 | 196.1 | 182.0 | 10/10 | 5+4 |
BH: body height, BW: body weight, WB: whole-body group, Dyn: dynamic group.
Positive biopsy indicates the number of cancer-positive biopsy cores and total cores obtained.